Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2022-03-17 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
西南证券股份有限公司关于北京颖泰嘉和生物科技股份有限公司部分募投项目延期的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from Southwest Securities regarding the delay of certain fundraising investment projects by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It discusses the background of the fundraising, the amount raised, the investment projects, reasons for the delay, and the approval process by the board, independent directors, and supervisory board. It is not a financial report or earnings release but rather a regulatory compliance and verification statement related to the use of raised funds and project delays. The document is relatively short (2916 characters) and serves as a formal opinion or announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and verification documents that do not fit other specific categories.
2022-03-17 Chinese
2021年年度报告
Annual Report Classification · 100% confidence The document is a comprehensive report from Beijing YingTai JiaHe Biotechnology Co., Ltd. for the fiscal year 2021, covering detailed financial data, management discussion and analysis, company overview, risk factors, and other extensive disclosures. It includes audited financial statements, management's discussion and analysis, and a standard unqualified audit opinion from an accounting firm. The document contains sections such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, internal control, and financial accounting reports. The presence of detailed financial statements, management analysis, audit report, and comprehensive disclosures for the full fiscal year strongly indicates this is an Annual Report. The document length (15,000 characters) and depth of content confirm it is not a mere announcement or summary but the full report itself. Therefore, the filing type is Annual Report (10-K). FY 2021
2022-03-17 Chinese
西南证券股份有限公司关于北京颖泰嘉和生物科技股份有限公司2021年度募集资金存放与使用情况的专项核查报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from Southwest Securities Co., Ltd. regarding the 2021 annual special verification of the deposit and use of raised funds by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes specific financial figures about the amount raised, usage, balances, and management of the raised funds during the 2021 fiscal year. The document references regulatory guidelines related to the management and use of raised funds and includes an auditor's verification opinion. The content focuses on the management and use of funds raised through a public stock issuance, which aligns with a specialized audit or verification report rather than a full annual report or earnings release. The document is not a brief announcement or a presentation but a comprehensive verification report on the use of raised funds, which fits the category of an Audit Report / Information (AR). FY 2021
2022-03-17 Chinese
关于治理专项自查及规范活动相关情况的报告
Governance Information Classification · 95% confidence The document is a detailed report on corporate governance self-inspection and compliance activities by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes information on company structure, internal systems, board and management roles, decision-making processes, and governance constraints. The content focuses on governance practices, internal controls, and compliance with relevant laws and listing rules. There is no financial data, earnings information, or audit results presented. The document is not an announcement of a report but the report itself, given its length (over 5,000 characters) and detailed content. The nature of the report aligns with Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2022-03-17 Chinese
关于召开2021年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2021 Annual General Meeting (AGM) of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes details about the meeting date, voting methods, agenda items to be discussed (such as the 2021 annual report, financial reports, and remuneration plans), and procedural information for shareholders. It does not contain the actual annual report or financial statements but references where these can be found. The document is relatively short (3306 characters) and serves as an announcement for the AGM rather than the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2022-03-17 Chinese
拟续聘会计师事务所公告
Audit Report / Information Classification · 90% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (Sichuan Huaxin Group CPA Firm) as the auditor for the 2022 fiscal year. It details the firm's background, audit fees, and the board's approval process. There are no actual financial statements or audit reports included, only information about the auditor and the approval process. The document length is 2811 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information (AR) type, since it relates to audit information but is not a full annual report or audit report itself. However, given the document is primarily an announcement of auditor reappointment and related information, it fits best under Audit Report / Information (AR). FY 2022
2022-03-17 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.